AU2006243644A1 - Use of phycotoxins in veterinary applications - Google Patents

Use of phycotoxins in veterinary applications Download PDF

Info

Publication number
AU2006243644A1
AU2006243644A1 AU2006243644A AU2006243644A AU2006243644A1 AU 2006243644 A1 AU2006243644 A1 AU 2006243644A1 AU 2006243644 A AU2006243644 A AU 2006243644A AU 2006243644 A AU2006243644 A AU 2006243644A AU 2006243644 A1 AU2006243644 A1 AU 2006243644A1
Authority
AU
Australia
Prior art keywords
gtx
composition
effective amount
activity
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2006243644A
Other languages
English (en)
Inventor
Nestor Antonio Lagos Wilson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phytotox Ltd
Original Assignee
Phytotox Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytotox Ltd filed Critical Phytotox Ltd
Publication of AU2006243644A1 publication Critical patent/AU2006243644A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2006243644A 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications Abandoned AU2006243644A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US67793305P 2005-05-05 2005-05-05
US60/677,933 2005-05-05
PCT/US2006/017449 WO2006119499A2 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications

Publications (1)

Publication Number Publication Date
AU2006243644A1 true AU2006243644A1 (en) 2006-11-09

Family

ID=37308745

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006243644A Abandoned AU2006243644A1 (en) 2005-05-05 2006-05-05 Use of phycotoxins in veterinary applications

Country Status (5)

Country Link
EP (1) EP1877058A4 (ja)
JP (1) JP2008540452A (ja)
AU (1) AU2006243644A1 (ja)
CA (1) CA2606315A1 (ja)
WO (1) WO2006119499A2 (ja)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200012833A (ko) * 2017-03-29 2020-02-05 사이트원 테라퓨틱스, 인코포레이티드 통증 치료용 11,13-개질된 색시톡신

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1324246A (zh) * 1998-10-27 2001-11-28 梅约医学教育与研究基金会 增加伤口愈合的方法
MXPA04004543A (es) * 2001-11-15 2005-03-31 Micro Algae Corp Composiciones farmaceuticas que contienen 3,4-propinoperhidropurinas y sus usos para el bloqueo de la transmision neuronal.
WO2005110417A1 (en) * 2004-05-07 2005-11-24 Phytotox Limited Phycotoxins and uses thereof

Also Published As

Publication number Publication date
JP2008540452A (ja) 2008-11-20
WO2006119499A2 (en) 2006-11-09
EP1877058A4 (en) 2008-06-25
EP1877058A2 (en) 2008-01-16
CA2606315A1 (en) 2006-11-09
WO2006119499A3 (en) 2006-12-28

Similar Documents

Publication Publication Date Title
AU2005244096B2 (en) Transdermal administration of phycotoxins
KR100764156B1 (ko) 국소 마취제의 국소 투여를 위한 피내 침투제
AU2005244105B2 (en) Phycotoxins and uses thereof
JP2953625B2 (ja) 薬剤／浸透促進組成物に関連する皮膚刺激を低下させる方法
AU2001245449A1 (en) Intradermal-penetration agents for topical local anesthetic administration
ES2228125T3 (es) Sistemas de suministro de farmacos originados en las mucosas.
JPS60152413A (ja) メントールにより経皮性薬剤放出の強化を行なつた局所用組成物
US20150297517A1 (en) New stable anesthetic composition for reducing skin reactions
WO2001041550A2 (en) Topical anesthetic formulation
AU2006243644A1 (en) Use of phycotoxins in veterinary applications
US20140018750A1 (en) Method and device or pharmaceutical compositions for the transdermal delivery of magnesium directly to the neuromuscular junction for the treatment of muscle cramping
CN111067919A (zh) 喷雾止痛剂
EP1406604A2 (en) Topical application of muscarinic analgesic drugs such as neostigmine

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period